The increasing incidence of dermatophytic infections and rising resistance to conventional antifungal agents necessitates the exploration of alternative therapies. This study investigates the antifungal potential of Curcuma longa rhizome extract against dermatophytes, particularly Trichophyton species, through a combination of in vitro and in silico techniques. The methanolic extract of Curcuma longa was evaluated for its antifungal efficacy using the disc diffusion method against Trichophyton mentagrophytes, Trichophyton indotineae, and Trichophyton interdigitale. The extract demonstrated significant antifungal activity, with inhibition zones ranging from 10 to 25 mm. Comparative analysis with fluconazole revealed that Curcuma longa extract was effective even against fluconazole-resistant strains. GC-MS analysis identified eleven major compounds, with Curlone (44.19%) as the dominant component. Molecular docking studies targeted lanosterol 14α-demethylase, a key enzyme in ergosterol biosynthesis, revealing strong binding affinities of Curlone, α-Curcumene, 3-Isobutylidene-6,7-dimethyl-3H-isobenzofuran-1-one, and 1-Bisabolone. These compounds demonstrated favorable interactions, suggesting their role in inhibiting fungal growth. Further, ADME and Toxicity analysis highlighted Curlone's superior pharmacokinetic and toxicity profile, making it a promising candidate for antifungal therapy. This study concludes that the extract of Curcuma longa shows promising potential as a natural alternative to traditional antifungal agents, and further investigation through in vivo studies is recommended.